Publicaciones (55) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. 3D printing of microencapsulated Lactobacillus rhamnosus for oral delivery

    International Journal of Pharmaceutics, Vol. 641

  2. A pharmacometrics model to define docetaxel target in early breast cancer

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 2, pp. 727-736

  3. A physiologically based pharmacokinetic model for V937 oncolytic virus in mice

    Frontiers in Pharmacology, Vol. 14

  4. Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery

    Biology, Vol. 12, Núm. 12

  5. Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling

    Clinical Pharmacology and Therapeutics, Vol. 114, Núm. 3, pp. 623-632

  6. Biomonitoring of 19 Mycotoxins in Plasma from Food-Producing Animals (Cattle, Poultry, Pigs, and Sheep)

    Toxins, Vol. 15, Núm. 4

  7. COVID-19 Publications in Allergy Journals, 2020-2021: A Bibliometric Analysis

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 2, pp. 131-133

  8. Cardiac tissue engineering for myocardial infarction treatment

    European Journal of Pharmaceutical Sciences, Vol. 185

  9. Co-Occurrence of Mycotoxins in Feed for Cattle, Pigs, Poultry, and Sheep in Navarra, a Region of Northern Spain

    Toxins, Vol. 15, Núm. 3

  10. DNA strand break levels in cryopreserved mononuclear blood cell lines measured by the alkaline comet assay: results from the hCOMET ring trial

    Mutagenesis, Vol. 38, Núm. 5, pp. 273-282

  11. Encapsulation of Lactobacillus plantarum in casein-chitosan microparticles facilitates the arrival to the colon and develops an immunomodulatory effect

    Food Hydrocolloids, Vol. 136

  12. Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment

    Molecules, Vol. 28, Núm. 15

  13. Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 121

  14. First Generation of Antioxidant Precursors for Bioisosteric Se-NSAIDs: Design, Synthesis, and In Vitro and In Vivo Anticancer Evaluation

    Antioxidants, Vol. 12, Núm. 9

  15. From Natural Sources to Synthetic Derivatives: The Allyl Motif as a Powerful Tool for Fragment-Based Design in Cancer Treatment

    Journal of Medicinal Chemistry, Vol. 66, Núm. 6, pp. 3703-3731

  16. Genotoxicity and Toxicity Assessment of a Formulation Containing Silver Nanoparticles and Kaolin: An In Vivo Integrative Approach

    Nanomaterials, Vol. 13, Núm. 1

  17. Gliadin nanoparticles for oral administration of bioactives: Ex vivo and in vivo investigations

    International Journal of Biological Macromolecules, Vol. 249

  18. Impact of physico-chemical properties on the toxicological potential of reduced graphene oxide in human bronchial epithelial cells

    Nanotoxicology, Vol. 17, Núm. 5, pp. 471-495

  19. In Vivo Genotoxicity and Toxicity Assessment of Sterigmatocystin Individually and in Mixture with Aflatoxin B1

    Toxins, Vol. 15, Núm. 8

  20. In vitro genotoxicity assessment of French fries from mass catering companies: a preliminary study

    Mutagenesis, Vol. 38, Núm. 1, pp. 51-57